The Oxford-Harrington Rare Disease Centre (OHC) brings together the strengths and capabilities of the University of Oxford in the UK and the Harrington Discovery Institute in Cleveland, Ohio, US. We are united in our mission to deliver cures for rare diseases.

Lord David Cameron was the Founding Chair of our Advisory Council and made a speech at the launch of our Accelerator on 2 October 2023.

Therapeutics Accelerator Signing October 2023 (L-R): Dr Jonathan Stamler, President, Harrington Discovery Institute; Prof Irene Tracey, Vice-Chancellor, University of Oxford; Dr Cliff Megerian, CEO, University Hospitals; Jim Wilkinson, CFO, OSE